Bandy appointment ties in with abiliti launch
This article was originally published in Clinica
Weight loss therapy specialist IntraPace has appointed Bart Bandy, a veteran in the bariartric and general surgery markets, chief commercial officer. Prior to joining the Mountain View, California firm, he was the senior vice-president at gastric band market leader Inamed/Allergan Health. He has also held senior sales, marketing and general management roles with Ethicon Endo-Surgery, Karl Storz, and USGI Medical. He joins IntraPace as the firm launches its flagship obesity treatment, the abiliti system, in Europe. The device, which is CE-marked but not yet approved in the US, is implanted on the anterior side of the stomach and electrically stimulates it so that the person feels full before the stomach is actually full. The system also automatically records when a patient eats, drinks and exercises and transmits these data wirelessly so that they can be viewed by patients and physicians.